NOTICE: Labnodes now supports vumc.org email addresses. If your email changed, please update your profile today.
  1. Alpha to Beta Cell Reprogramming: Stepping toward a New Treatment for Diabetes. Osipovich AB, Magnuson MA (2018) Cell Stem Cell 22(1): 12-13
    › Primary publication · 29304337 (PubMed)
  2. Chronic β-Cell Depolarization Impairs β-Cell Identity by Disrupting a Network of Ca-Regulated Genes. Stancill JS, Cartailler JP, Clayton HW, O'Connor JT, Dickerson MT, Dadi PK, Osipovich AB, Jacobson DA, Magnuson MA (2017) Diabetes 66(8): 2175-2187
    › Primary publication · 28550109 (PubMed) · PMC5521870 (PubMed Central)
  3. Setd5 is essential for mammalian development and the co-transcriptional regulation of histone acetylation. Osipovich AB, Gangula R, Vianna PG, Magnuson MA (2016) Development 143(24): 4595-4607
    › Primary publication · 27864380 (PubMed) · PMC5201031 (PubMed Central)
  4. Pancreatic Inflammation Redirects Acinar to β Cell Reprogramming. Clayton HW, Osipovich AB, Stancill JS, Schneider JD, Vianna PG, Shanks CM, Yuan W, Gu G, Manduchi E, Stoeckert CJ, Magnuson MA (2016) Cell Rep 17(8): 2028-2041
    › Primary publication · 27851966 (PubMed) · PMC5131369 (PubMed Central)
  5. Insm1 promotes neurogenic proliferation in delaminated otic progenitors. Lorenzen SM, Duggan A, Osipovich AB, Magnuson MA, García-Añoveros J (2015) Mech Dev : 233-45
    › Primary publication · 26545349 (PubMed) · PMC4679445 (PubMed Central)
  6. Activation of FoxM1 Revitalizes the Replicative Potential of Aged β-Cells in Male Mice and Enhances Insulin Secretion. Golson ML, Dunn JC, Maulis MF, Dadi PK, Osipovich AB, Magnuson MA, Jacobson DA, Gannon M (2015) Diabetes 64(11): 3829-38
    › Primary publication · 26251404 (PubMed) · PMC4613976 (PubMed Central)
  7. Insm1 promotes endocrine cell differentiation by modulating the expression of a network of genes that includes Neurog3 and Ripply3. Osipovich AB, Long Q, Manduchi E, Gangula R, Hipkens SB, Schneider J, Okubo T, Stoeckert CJ, Takada S, Magnuson MA (2014) Development 141(15): 2939-49
    › Primary publication · 25053427 (PubMed) · PMC4197673 (PubMed Central)
  8. Impaired islet function in commonly used transgenic mouse lines due to human growth hormone minigene expression. Brouwers B, de Faudeur G, Osipovich AB, Goyvaerts L, Lemaire K, Boesmans L, Cauwelier EJ, Granvik M, Pruniau VP, Van Lommel L, Van Schoors J, Stancill JS, Smolders I, Goffin V, Binart N, in't Veld P, Declercq J, Magnuson MA, Creemers JW, Schuit F, Schraenen A (2014) Cell Metab 20(6): 979-90
    › Citation · 25470546 (PubMed) · PMC5674787 (PubMed Central)
  9. Pancreas-specific Cre driver lines and considerations for their prudent use. Magnuson MA, Osipovich AB (2013) Cell Metab 18(1): 9-20
    › Primary publication · 23823474 (PubMed) · PMC3732107 (PubMed Central)
  10. Quantification of factors influencing fluorescent protein expression using RMCE to generate an allelic series in the ROSA26 locus in mice. Chen SX, Osipovich AB, Ustione A, Potter LA, Hipkens S, Gangula R, Yuan W, Piston DW, Magnuson MA (2011) Dis Model Mech 4(4): 537-47
    › Primary publication · 21324933 (PubMed) · PMC3124063 (PubMed Central)